Other languages OncoSil Medical Limited

Equities

OSL

AU000000OSL3

Market Closed - Australian S.E. Other stock markets 02:10:44 2024-04-26 am EDT			5-day change	1st Jan Change
0.004 ^AUD	-20.00%		-42.86%	-55.56%

Apr. 18	OncoSil Medical Treats Two More Patients in Netherlands in Pancreatic Cancer Trial	MT
Apr. 16	OncoSil Medical Treats First Commercial Patient in Turkey with Implantable Pancreatic Cancer Device	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Oncosil Medical to Raise Over AU$7 Million via Placement, Entitlement Offer	Mar. 19
OncoSil Medical Limited Reports Earnings Results for the Half Year Ended December 31, 2023	Feb. 28
Australian Shares End Eight-Day Winning Streak as Early US Fed Rate Cut Hopes Fade	Feb. 01
OncoSil Device Included in German Funding Program Negotiations; Shares Jump 14%	Jan. 31
OncoSil Strikes Exclusive Distribution Deal For Turkish Market; Shares Jump 14%	Jan. 31
OncoSil Medical Receives AU$1.1 Million R&D Tax Rebate	Dec. 15
Oncosil Medical Limited Elects Gabrielle Liberatore as Director	Nov. 28
Australian Shares Rise on Expectations of Easing October CPI	Nov. 24
OncoSil Medical Limited Announces Retirement of Brian Leedman from the Board	23-09-18
OncoSil Medical Limited Reports Earnings Results for the Full Year Ended June 30, 2023	23-08-31
OncoSil Medical Limited Appoints Doug Cubbin as Director	23-08-09
OncoSil Appoints Gabriel Liberatore to the Board	23-07-14
OncoSil Medical Secures Ethics Approval for Pancreatic Cancer Trial	23-06-05
OncoSil Medical Ltd Announces Change of Company Secretary	23-05-31
Oncosil Medical CFO Resigns	23-05-24
Oncosil Medical Ltd Announces Resignation of Karl Pechmann as Company Secretary	23-05-23
OncoSil Medical Treats First Cancer Patient in Italy; Shares Fall 7%	23-05-22
Oncosil Medical Enrolls First Patient in Clinical Study of Pancreatic Cancer Treatment	23-05-03
OncoSil Medical Expects to Save AU$1 Million from Restructure; Shares Down 8%	23-05-02
OncoSil Medical Advances Commercialization of Implantable Device in Spain; Shares Surge 30%	23-04-24

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages OncoSil Medical Limited

Equities

OSL

AU000000OSL3

Other languages

Filters